Manmeet Ahluwalia, MD, MBA, Miami Cancer Institute, discussed efforts being taken by his organization’s Center for Equity in Cancer Care & Research to address disparities in clinical trial enrollment of minority patients in the United States.
The Center for Equity in Cancer Care & Research aims to bridge the significant gap in enrollment of minority patients within clinical trials that lead to FDA approval of oncology drugs, said Manmeet Ahluwalia, MD, MBA, chief, Solid Tumor Medical Oncology, deputy director, and chief scientific officer at Miami Cancer Institute.
Transcript
Can you speak on the community-level health inequities among the populations you serve with Miami Cancer Institute and how these factors have influenced strategies at the new Center for Equity in Cancer Care & Research?
Despite all the advances in cancer care [in the] United States, there is a significant disparity in care of patients who are minority in origin. For example, if you look at clinical trials that lead to FDA approval of drugs in oncology, only 3% to 4% of those patients are African American in origin and only 3% to 4% of those patients are in Hispanic origin. Whereas you look at the United States population, 20% of the United States population is Hispanic origin, and 13% to 14% is African American.
So, when you add these 2, African Americans and Hispanics, although they constitute one-third of the US population, only 5% to 6% of these patients are enrolled in clinical trials. So, a major emphasis of our program is to bolster the minority enrollment in clinical trials. And as a primarily Hispanic-serving institution, we have a major focus in building the trust, and we are doing that through our partners in the community.
We have launched several initiatives where we are taking advantage of community health care workers, and we are working closely with Health Council of South Florida to partner to increase the minority enrollment to clinical trials and bridge this gap of minorities in trials that lead to FDA approval of drugs, which is a major emphasis for the White House, the National Institutes of Health, National Cancer Institute, and the FDA. Miami Cancer Institute is bolstering this initiative with our efforts in South Florida. And to this, we've been lucky to [receive] a generous donation from one of our philanthropic partners who have given us $2 million to organize and operationalize the center, which will be key to driving these efforts locally and then partnering with people nationally.
Public Hospitals More Likely to Extend Unprofitable Services After 340B Participation, Study Finds
May 10th 2024Public hospitals were significantly more likely to sustain access to unprofitable services following 340B Drug Pricing Program participation, while nonprofit hospitals were mostly unaffected, according to a recent study.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Persistence Pays Off With Zanubrutinib: A Challenging CLL Case With a Prior BTK Inhibitor Failure
May 10th 2024The case of a 77-year-old woman with a long chronic lymphocytic leukemia (CLL) history illustrates the novel use of zanubrutinib as a potential option for some patients who have failed first-generation Bruton tyrosine kinase (BTK) inhibitors and venetoclax.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Health Equity, Accessibility Essential to Supporting Women Affected by Hemophilia
May 10th 2024Due to often being overlooked as only carriers of hemophilia, the review authors sought to highlight the needs of female caretakers for patients with the disorder and the possibility of women themselves being affected by it.
Read More